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Conventional DNA profiling of Short Tandem Repeats (STR) provides little evidentiary 
value in the absence of reference profiles or in the case of a non-match. Recently, the 
forensic DNA intelligence field has flourished to provide investigators with valuable 
information from DNA samples that can narrow the collection of potential matches by 
identifying previously unknown reference individuals. Intelligence data of special 
interest includes the biogeographical ancestry (BGA) and external visible characteristics 
(EVC) such as the eye, hair and skin colour of unknown DNA samples donors. 
Innovative technological advances like next-generation sequencing and microarrays 
have been crucial to the establishment of population diversity repositories comprising 
millions of DNA markers, the most abundant of which include single nucleotide 
polymorphisms (SNPs). Large-scale SNP studies of global populations have enabled 
reconstructions of mitochondrial (mtDNA) and non-recombining Y-chromosome 
(NRY) phylogenies, providing highly comprehensive population specific patterns of 
maternal and paternal genetic variation. Similarly, numerous patterns of autosomal 
genetic variation have been identified between different populations. These studies have 
culminated in panels of markers capable of resolving ancestry at the continental level. 
The identification of autosomal SNPs associated with human pigmentation variation has 
also resulted in the discovery of specific SNPs capable of predicting EVCs. Several 
DNA intelligence and phenotyping assays for the inference of BGA and for the 
prediction of eye, hair and skin colour have subsequently been developed. However, 
most of these intelligence tools have primarily focused on the analysis of one class of 
SNPs, hence limiting the amount of ancestry intelligence that could be obtained. The 
scarcity and often environmentally compromised nature of forensic biological evidence 
means that performing numerous individual intelligence tests is not optimal and a 
consolidated DNA intelligence diagnostic test is very much needed.  
This study aimed to develop a SNP genotyping system that combined autosomal, NRY 
and mtDNA markers for comprehensive predictions of BGA and EVCs. Candidate 
SNPs were selected through literature and database searches to identify loci exhibiting 
skewed allele frequency differences between Sub-Saharan African, North African, 
Middle Eastern, European, South and East Asian populations. A hierarchical 
xxiv 
arrangement comprising five separate multiplexes was implemented, in which SNP 
typing was performed by single-base extension assays. The haploid mtDNA and NRY 
SNPs were grouped into Multiplex 1 to 4, with SNPs defining maternal and paternal 
lineages (haplogroups) affiliated with the same geographic region grouped in the same 
reaction. The markers defining basal haplogroups were included in Multiplex 1, which 
is then used to identify the subsequent multiplex(es) required to achieve further 
haplogroup resolution and to minimise the number of tests required. The autosomal 
SNPs are typed separately in Multiplex 5.  
A performance evaluation of the 5-multiplex SNP assay was undertaken on 146 
individuals originating from the six major population groups of interest. Population 
genetic analyses of the mtDNA and NRY haplotypes and autosomal genotypes revealed 
that a greater degree of population differentiation was achieved with the selected NRY 
and autosomal SNPs than with the mtDNA SNPs. Moreover, the results indicated that 
the assay primarily allowed for the differentiation of continental ancestry, with 
populations in close proximity within continents, such as Europe, the Middle East and 
South Asia, often difficult to distinguish. However, the observed correlation between 
the declared and inferred geographic regions of maternal and paternal origin was high; 
73-100% for maternal and 79-100% for paternal regional BGA. The bi-parental BGA 
predictions ranged from 85 to 95%, provided Middle Easterners and Europeans were 
grouped into a single Western Eurasian population. In 99% of cases, two of the three 
SNP classes correctly predicted the same ancestry from one of the five broad 
geographical regions (Sub-Saharan Africa, North Africa, Western Eurasia, South Asia 
and East Asia). High prediction accuracies were also observed for the inference of 
EVCs including hair (86-88%) and eye colour (81-95%). The DNA intelligence assay 
also demonstrated advanced performance with low starting amounts of genomic DNA, 
with full profiles observed for up to 100pg of template and for the analysis of routine 
casework biological samples. Consequently, this study presented the successful 
development of a novel, consolidated DNA intelligence tool that has displayed high 
performance for the inference of regional (continental) BGA and EVC in preliminary 
tests. Further validations of the assay are required; however the developed 5-multiplex 
SNP assay remains a valuable DNA intelligence diagnostic tool for the forensic science 
community. 
